S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Final stage before digital money (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Final stage before digital money (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Final stage before digital money (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain
S&P 500   4,191.98
DOW   33,426.63
QQQ   336.51
Mount Etna volcano erupts, raining ash on Catania, forcing flight suspension at local airport
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
China tells tech manufacturers to stop using Micron chips, stepping up feud with United States
Stock market today: Global shares mostly rise despite worries about US debt talks
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
SpaceX launches two Saudi astronauts on private flight to space station
Civil rights groups warn tourists about Florida in wake of 'hostile' laws
Final stage before digital money (Ad)
South Korean, German leaders agree to cooperate on supply chains, North Korea
Animal rights activists protest octopus farm plans in Spain

2 Stocks Popping After Analyst Upgrades

Albemarle Corporation (NYSE:ALB) and DuPont de Nemours Inc (NYSE:DD) both sport healthy leads this morning, after analysts upgraded the two stocks.

Baird upgraded ALB to "outperform" from "neutral" and hiked its price target to $288. noting the lithium maker's shares could add more than 45% and may be a near- and long-term leader. The equity is up 4.5% to trade at $204.53 at last glance, rallying back from its late-April, 12-month low of $171.93. Year-to-date, however, Albemarle stock is 6.2% lower.

Call traders are taking up space in ALB's normally quiet options pits. Already today, 3,616 bullish bets have been traded, which is double the amount typically seen at this point. Most popular is the May 210 call, indicating these traders see more gains to be had by this week's end.

DuPont de Nemours stock is 2.3% higher to trade at $65.22 at last check, after Deutsche Bank praised its price compared to its peers. The Wall Street firm upgraded the chemical stock to "buy" from "hold" and raised its price objective to $80 from $70, noting it is 50% more affordable than its competitors.

This bull note is in stark contract to recent analyst sentiment, as a deluge of price-target cuts rolled in after the company's early May earnings report. In fact, that quarterly outing resulted in a bear gap that DD is still attempting to recover from, and contributed to its 5.1% year-to-date deficit.

Where should you invest $1,000 right now?

Before you make your next trade, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Our team has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and none of the big name stocks were on the list.

They believe these five stocks are the five best companies for investors to buy now...

See The Five Stocks Here

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by entering your email address below.

Get This Free Report
20 Stocks to Sell Now Cover

Featured Articles and Offers

Search Headlines:

My Account -